Literature DB >> 16603961

Coats disease: a lifetime disease.

Gary Shienbaum1, William S Tasman.   

Abstract

PURPOSE: To document the recurrent nature of Coats Disease.
METHODS: This study is a retrospective chart review approved by our Institutional Review Board. Thirteen patients (13 eyes) were diagnosed with Coats Disease starting in 1966. Age, visual acuity, time of onset, method of treatment, and the number and intervals of recurrences were documented. Recurrences were recorded once initial treatment proved successful and most exudates had absorbed. The length of follow-up for each patient and the most recent visual acuity was recorded.
RESULTS: The average follow-up period for the 13 patients was 12.4 years with a range from 4.0 to 37.5 years. Eleven patients (85%) were male, two (15%) were female and all had unilateral involvement. The average age at diagnosis was 7.0 years with a range from 9 months to 27 years. Four out of the twelve treated patients (33%) had recurrences, and three of the four had multiple recurrences. The average elapsed time from successful treatment to the first recurrence was 4.3 years with a range from 3.3 to 5.4 years. The average number of recurrences was 3.3.
CONCLUSION: Coats Disease can recur so it is important that parents educate any affected children regarding the necessity of follow-up, including throughout their adult years.

Entities:  

Mesh:

Year:  2006        PMID: 16603961     DOI: 10.1097/01.iae.0000238545.44132.a2

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  9 in total

1.  Coats disease in adolescence and adulthood with preserved vision after laser photocoagulation monotherapy: two case reports.

Authors:  Gitalisa Andayani Adriono; Andi Marsa Nadhira; Sausan Rasyid Mahfudz
Journal:  J Med Case Rep       Date:  2022-07-18

2.  Coats' disease: an Indian perspective.

Authors:  Pukhraj Rishi; Ekta Rishi; Mahesh Uparkar; Tarun Sharma; Lingam Gopal; Pramod Bhende; Muna Bhende; Pratik Ranjan Sen; Parveen Sen
Journal:  Indian J Ophthalmol       Date:  2010 Mar-Apr       Impact factor: 1.848

3.  Treatment of stage 3 Coats' disease by endolaser photocoagulation via a two-port pars plana nonvitrectomy approach.

Authors:  Xuan Cai; Peiquan Zhao; Qi Zhang; Haiying Jin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-03-21       Impact factor: 3.117

4.  Late re-activation of Coats disease.

Authors:  Itsara Lertjirachai; Edward H Wood; Omar Moinuddin; Kimberly A Drenser
Journal:  Am J Ophthalmol Case Rep       Date:  2019-04-25

5.  Clinical features and prognostic factors in 71 eyes over 20 years from patients with Coats' disease in Korea.

Authors:  Hyun Goo Kang; Jung Dong Kim; Eun Young Choi; Suk Ho Byeon; Sung Soo Kim; Hyoung Jun Koh; Min Kim
Journal:  Sci Rep       Date:  2021-03-17       Impact factor: 4.379

6.  Bilateral Coats' Disease Combined with Retinopathy of Prematurity.

Authors:  Huseyin Gursoy; Nazmiye Erol; Mustafa Deger Bilgec; Hikmet Basmak; Ozden Kutlay; Huseyin Aslan
Journal:  Case Rep Ophthalmol Med       Date:  2015-08-30

7.  Advanced Coats' disease treated with intravitreal bevacizumab combined with laser vascular ablation.

Authors:  Victor M Villegas; Aaron S Gold; Audina M Berrocal; Timothy G Murray
Journal:  Clin Ophthalmol       Date:  2014-05-16

8.  Fluorescein Angiographic Abnormalities in the Contralateral Eye with Normal Fundus in Children with Unilateral Coats' Disease.

Authors:  Eun Hye Jung; Jeong Hun Kim; Seong Joon Kim; Young Suk Yu
Journal:  Korean J Ophthalmol       Date:  2018-01-25

9.  The efficacy of conbercept or ranibizumab intravitreal injection combined with laser therapy for Coats' disease.

Authors:  Longli Zhang; Yifeng Ke; Wei Wang; Xueying Shi; Kaiwen Hei; Xiaorong Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-03-16       Impact factor: 3.117

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.